LEO Pharma

LEO Pharma is a global pharmaceutical company dedicated to advancing medical dermatology and improving skin health for patients worldwide. With a legacy spanning over a century, LEO Pharma develops and delivers innovative treatments for a range of dermatological conditions, reaching nearly 100 million patients across more than 70 countries annually.

As a purpose-driven organization co-owned by the LEO Foundation and Nordic Capital, LEO Pharma offers a collaborative and impactful environment for professionals seeking to contribute to meaningful advancements in healthcare. The company employs a team of 4,000 individuals globally, focused on pioneering solutions and making a fundamental difference in the lives of those affected by skin diseases.